ROBERTS EIRY bought NBIX
November 8, 2024 · Form 4 insider transaction
ROBERTS EIRY bought 5,140 shares of Neurocrine Biosciences, Inc. at $77.81 per share, a transaction worth $399.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,140
Price
$77.81
Total value
$399.9K
InsiderROBERTS EIRY
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 8, 2024
Filing dateNovember 12, 2024
Shares owned after28,856
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.